NCT00769548View on ClinicalTrials.gov

Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

1,322

Participants

Timeline

Start Date

April 30, 1995

Primary Completion Date

April 30, 2001

Study Completion Date

December 31, 2016

Conditions
Prostate Cancer
Interventions
DRUG

flutamide

Drug used for TAS.

DRUG

goserelin acetate

Drug used for TAS.

RADIATION

low-LET photon therapy

radiation therapy

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Radiation Therapy Oncology Group

NETWORK

NCT00769548 - Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter